Home Cart Sign in  
Chemical Structure| 1000787-75-6 Chemical Structure| 1000787-75-6

Structure of Tegobuvir
CAS No.: 1000787-75-6

Chemical Structure| 1000787-75-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tegobuvir is a non-nucleoside nonstructural protein (NS)5B polymerase inhibitor.

Synonyms: GS-9190; GS 333126; TGV

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tegobuvir

CAS No. :1000787-75-6
Formula : C25H14F7N5
M.W : 517.40
SMILES Code : FC1=CC=CC=C1C2=NC3=CN(CC4=NN=C(C5=CC=C(C(F)(F)F)C=C5C(F)(F)F)C=C4)C=CC3=N2
Synonyms :
GS-9190; GS 333126; TGV
MDL No. :MFCD18251457
InChI Key :XBEQSQDCBSKCHJ-UHFFFAOYSA-N
Pubchem ID :23649154

Safety of Tegobuvir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P264-P270-P301+P312-P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Huh7 cells 1 µM 30 minutes Evaluate the effect of Tegobuvir on HEV-RdRp enzyme activity, results showed Tegobuvir did not significantly inhibit HEV-RdRp activity ACS Omega. 2023 Oct 27;8(44):41570-41578
Huh-7 cells 0.01 nM to 100 µM 72 hours Evaluate the inhibitory activity of Tegobuvir against HCV G1b, G2a, and G3a subgenomic replicons. Results showed that Tegobuvir had an EC50 of 3.2 nM for the G1b replicon but significantly reduced activity against G2a and G3a replicons, with 3,400-fold and 822-fold increases in EC50, respectively. Antimicrob Agents Chemother. 2014 Dec;58(12):7215-24

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.66mL

1.93mL

0.97mL

19.33mL

3.87mL

1.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories